Pregled bibliografske jedinice broj: 580088
Glutathione adduct of hemoglobin (Hb ASSG) in hemolysates of patients on long-term antiepileptic therapy
Glutathione adduct of hemoglobin (Hb ASSG) in hemolysates of patients on long-term antiepileptic therapy // International journal of biochemistry, 24 (1992), 3; 503-507 doi:10.1016/0020-711x(92)90046-4 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 580088 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Glutathione adduct of hemoglobin (Hb ASSG) in
hemolysates of patients on long-term
antiepileptic therapy
Autori
Niketić, Vesna ; Bešlo, Drago ; Raičević, Smiljana ; Sredić, Slavica ; Stojković, Mira
Izvornik
International journal of biochemistry (0020-711X) 24
(1992), 3;
503-507
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
hemoglobin ; patinets ; long-term therapy
Sažetak
1. A novel, hitherto unrecognized, hemoglobin fraction, HbA1x, has been detected in amounts up to 7% of the total Hb, in hemolysates from epileptic patients with long-term therapy containing phenobarbital (PB) and carbamazepine (Carb). 2. HbA1x was shown to represent glutathione adduct of Hb (Hb ASSG). 3. To our knowledge, this is the first demonstration of the occurrence of Hb ASSG in vivo.
Izvorni jezik
Engleski
Znanstvena područja
Biologija
Poveznice na cjeloviti tekst rada:
Pristup cjelovitom tekstu rada doi dx.doi.org www.sciencedirect.comCitiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
